+ 1 (866) 764-2259 cs@conferencestime.com
Pharmaceutical

ChatGPT / AI for Project Management for FDA-Regulated Companies

Live Webinar
Presented by - John E. Lincoln
DATE
03 MAR 2026
TIME
1:00 PM EST
DURATION
90 min
DAYS LEFT
4
John E. Lincoln
Description:

This webinar will provide valuable guidance to regulated companies in development and implementation of Project Management Planning and Techniques with ChatGPT / AI assistance for new product development, regulatory compliance audit responses, proof of "progress against plan", and other activities requiring a planned documented rationale.

Three of the most common tools will be discussed. One very simple approach using common Excel-or Word-type PC applications programs that can be used immediately. Regular use of a few simple but powerful tools will virtually eliminate "fire fighting" in a new project.

ChatGPT / AI assistance come with some uniques problems / dangers which must be addressed. Regular use can contribute greatly to reduction of scheduling uncertainty, incomplete projects when time is running out, increased product liability, assist in company-wide cost reduction efforts, with less chance of recalls, and an improved bottom line.

Areas Covered in the Session:-

  • Why formal Project Management
  • The three most common tools
  • ChatGPT / AI - Tools and Dangers
  • Gantt, CPM, PERT
  • Simple construction techniques
  • Work breakdown Structure, Milestones, Tasks
  • Effectiveness - Determining and Monitoring
  • The "New Product Example"
  • The "Remediation Example"
  • How to compile.

Why You Should Attend:-

The FDA expects companies to manage projects formally to include regulatory requirements, design and/or change control, with consideration of all applicable standards. The EU MDR and their notified bodies are no different.

How can this be done from a project's inception? Can ChatGPT / AI be used to facilitate the process? How can a Project Leader or Project Manager ensure critical elements are not omitted until late in the project when disaster looms? How to minimize scope creep? How to conclude a project "on time" and "within budget"? How to gain management support for the Milestones, Tasks, Timelines? Use the Plan as a powerful tool with FDA auditors. Use variations on these tools for any project, from the smallest to major company projects. What are the advantages / disadvantages of using Chat GBT (et al) / AI to assist in project management? Where best used? Current problems / dangers? Buy up-front time for proper project planning.

These techniques are not rocket-science, but require the implementation of formal methods with documented, and defensible rationale. Use these tools to bring predictability to your company's product development process. Use them to defend your remediation efforts with the FDA. Use them to prove "progress against plan".

Who Will Benefit:-

  • Senior Management in Pharmaceuticals
  • QA / RA
  • AI Software Programming, Documentation, Testing Teams
  • R&D
  • Engineering
  • Production
  • Operations
  • Marketing
  • Consultants.

Select Training Options

Selected Total
$0

Plan Your Learning

with
Event Calender

Explore Calendar
Meet Your Expert
John E. Lincoln
John E. Lincoln

John E. Lincoln is the Principal of J. E. Lincoln and Associates LLC, a consulting company, with over 32 years of experience in U.S. FDA-regulated industries, 18 of which as a full-time independent FDA-regulated industry consultant. Mr. Lincoln has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China, and Taiwan. He specializes in quality assurance, regulatory affairs, QMS / CGMP audits, problem remediation and FDA responses, new/changed product 510(k)s, process/product/equipment including QMS and software validations, ISO 14971 product risk management files/reports, Design Control / Design History Files, Technical Files. He’s held positions in Manufacturing Engineering, QA, QAE, and Regulatory Affairs, to the level of Director and VP (R&D).